March Biosciences (March Bio), an emerging clinical stage biotechnology company committed to combating challenging cancers and other diseases, today announced that the first patient has been dosed in ...

Houston-based March Biosciences, launched from the Center for Cell and Gene Therapy (Baylor College of Medicine, Houston Methodist Hospital, Texas Children’s Hospital), is dedicated to ...

Houston-based March Biosciences, launched from the Center for Cell and Gene Therapy (Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital), is dedicated to addressing ...

Biosciences announced the first patient has been dosed in its Phase 2 trial of MB-105, a first-in-class CD5-targeted CAR-T ...

The trial will test MB-105 in up to 46 patients with relapsed or refractory CD5-positive cutaneous T-cell lymphoma or peripheral T-cell lymphoma.

Researchers at Baylor College of Medicine, Texas Children’s Hospital, the Hospital for Sick Children in Toronto and collaborating institutions reveal in Nature Cell Biology a strategy that helps ...

Baylor College of Medicine. "New research points out a promising strategy for treating metastatic medulloblastoma." ScienceDaily. www.sciencedaily.com / releases / 2025 / 04 / 250422190641.htm ...

Isabel Valdez, physician assistant and associate professor of medicine at Baylor College of Medicine, explains how to maintain weight loss healthily after completing these medications. “Once you stop ...

The No. 1-ranked Baylor acrobatics and tumbling team defeated the No. 2 Oregon Ducks in the NCATA national final on Saturday, ...

For the second year in a row, Baylor was shut out of the NFL Draft, big six former Bears will get their shot as undrafted ...